|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
22
|
|
pubmed:dateCreated |
2011-7-29
|
|
pubmed:abstractText |
The management of glioblastoma multiforme (GBM) in elderly patients with poor performance status is not well established. A trial evaluating the efficacy and safety of temozolomide alone in this population was undertaken.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
pubmed-author:BarrieMarylineM,
pubmed-author:BeauchesnePatrickP,
pubmed-author:CampelloChantalC,
pubmed-author:Cartalat-CarelStéphanieS,
pubmed-author:Catry-ThomasIsabelleI,
pubmed-author:ChinotOlivierO,
pubmed-author:DelattreJean-YvesJY,
pubmed-author:DucrayFrançoisF,
pubmed-author:Gállego Pérez-LarrayaJaimeJ,
pubmed-author:GuillamoJean-SébastienJS,
pubmed-author:HonnoratJérômeJ,
pubmed-author:HuchetAymeriA,
pubmed-author:MattaMonaM,
pubmed-author:MokhtariKarimaK,
pubmed-author:MonjourAnnickA,
pubmed-author:TaillandierLucL,
pubmed-author:TanguyMarie-LaureML
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
29
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3050-5
|
|
pubmed:meshHeading |
pubmed-meshheading:21709196-Aged,
pubmed-meshheading:21709196-Aged, 80 and over,
pubmed-meshheading:21709196-Antineoplastic Agents, Alkylating,
pubmed-meshheading:21709196-Brain Neoplasms,
pubmed-meshheading:21709196-Cognition,
pubmed-meshheading:21709196-DNA Methylation,
pubmed-meshheading:21709196-DNA Modification Methylases,
pubmed-meshheading:21709196-DNA Repair Enzymes,
pubmed-meshheading:21709196-Dacarbazine,
pubmed-meshheading:21709196-Disease-Free Survival,
pubmed-meshheading:21709196-Drug Administration Schedule,
pubmed-meshheading:21709196-Female,
pubmed-meshheading:21709196-France,
pubmed-meshheading:21709196-Glioblastoma,
pubmed-meshheading:21709196-Humans,
pubmed-meshheading:21709196-Kaplan-Meier Estimate,
pubmed-meshheading:21709196-Karnofsky Performance Status,
pubmed-meshheading:21709196-Male,
pubmed-meshheading:21709196-Polymerase Chain Reaction,
pubmed-meshheading:21709196-Prospective Studies,
pubmed-meshheading:21709196-Quality of Life,
pubmed-meshheading:21709196-Questionnaires,
pubmed-meshheading:21709196-Treatment Outcome,
pubmed-meshheading:21709196-Tumor Suppressor Proteins
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Temozolomide in elderly patients with newly diagnosed glioblastoma and poor performance status: an ANOCEF phase II trial.
|
|
pubmed:affiliation |
Service de Neurologie 2-Mazarin, Groupe Hospitalier Pitié-Salpêtrière, 47-83 Blvd de l'Hôpital, Paris, France.
|
|
pubmed:publicationType |
Journal Article,
Multicenter Study,
Clinical Trial, Phase II
|
